Press release
Migraine Drugs Market Size Projected To Reach $7.22 Billion By 2034 With A Cagr Of 5.8%
Migraine Drugs
What Is the Projected Growth of the Migraine Drugs Market?
In recent times, there has been a robust growth in the size of the migraine drugs market. The value of the market is projected to escalate from $5.38 billion in 2024 to $5.77 billion in 2025, implying a compound annual growth rate (CAGR) of 7.2%. Factors such as developments in drug formulations, increase in awareness and diagnosis, stress and lifestyle aspects, enlargement of generic drugs, and appearance of cgrp inhibitors have majorly contributed to this growth during the historic phase.
The market for migraine medications is predicted to witness robust expansion in the coming years, reaching a value of $7.22 billion in 2029 with a compound annual growth rate (CAGR) of 5.8%. Factors contributing to its growth during the project period include the adoption of personalized medicine, telemedicine practices, and remote consultations, various healthcare policies and insurance coverage, an increasing worldwide prevalence of migraines, and combination treatments. Targeted therapies, telemedicine and remote consultations, patient-focused strategies, digital health solutions, the rise of biosimilars in migraine management, and extensive clinical research and trials are anticipated as the primary trends for the forecasted period.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13484
What Are the Different Migraine Drugs Market Segments?
The migraine drugs market covered in this report is segmented -
1) By Drug Class: Triptans, Betablockers, Angiotensin Blockers, Tricyclics, Anticonvulsants
2) By Route of Administration: Oral, Injectable, Other Routes
3) By End-User: Hospitals And Clinics, Retail Pharmacy, Online Pharmacy, Other End Users
Subsegments:
1) By Triptans: Sumatriptan, Rizatriptan, Zolmitriptan, Eletriptan
2) By Beta Blockers: Propranolol, Metoprolol, Timolol
3) By Angiotensin Blockers: Candesartan, Losartan
4) By Tricyclics: Amitriptyline, Nortriptyline
5) By Anticonvulsants: Topiramate, Valproate
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13484&type=smp
What Are the Primary Drivers Shaping the Migraine Drugs Market?
The anticipated growth of the migraine drugs market is partly attributed to the increasing female population. This demographic consists of females of every age group residing in a given country or region within a specific time frame. Migraines tend to occur more frequently in females than males, largely due to a mix of genetic, environmental, and hormonal factors. For instance, United Nations' World Population Prospects 2022 forecasted that by 2022, women would make up roughly 49.75% of the global population, equating to around 4.00 billion individuals. They also projected that the female population would surpass the male population by 2049. With this in mind, the expansion of the female population stands as a significant factor contributing to the development of the migraine drugs market. The surge in migraine prevalence is also believed to be a potent driver for the growth of the migraine drug market. Migraine is defined as a recurring condition presenting mild to severe pulsating and pounding pain typically localized to one side of the brain. The mounting incidence of migraines stimulates the demand for migraine drugs, thereby promoting the discovery and delivery of effective medications by pharmaceutical companies in a bid to meet the needs of a growing patient population. To illustrate, a report by the Australian Treasury, known as the Migraine Australia 2022-23 Pre-Budget Submissions, revealed in March 2023 that Australia had a remarkably high migraine rate of 28%, accounting for one in every four individuals and surpassing the combined prevalence of type 2 diabetes, epilepsy, and asthma. Therefore, the climbing rate of migraines stands as a crucial driver of the migraine drug market.
Which Companies Are Leading in the Migraine Drugs Market?
Major companies operating in the migraine drugs market report are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Merck & Co. Inc., AbbVie Inc., AbbVie Inc., Sanofi SA, Novartis AG, AstraZeneca, Abbott Laboratories, GlaxoSmithKline plc., Eli Lilly and Company, Amgen Inc., Otsuka Holdings Co. Ltd., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Eisai Co. Ltd., Dr Reddy's Laboratories Ltd., H. Lundbeck A/S, Amneal Pharmaceuticals Inc., Endo Pharmaceuticals Inc., Neurelis Inc., ALDER BIOPHARMACEUTICALS INC., eNeura Inc., Winston Pharmaceuticals Ltd.
What Are the Major Trends Shaping the Migraine Drugs Market?
Leading companies in the migraine drugs market are focusing their efforts on the creation of novel products such as Zavzpret, with the goal of improving patient care and securing a competitive advantage in the industry. Zavzpret is a breakthrough nasal spray treatment designed for adults suffering from acute migraines, with or without aura. For example, Pfizer, a prominent US pharmaceutical company, was granted approval for Zavzpret by the Food and Drug Administration, a US federal agency, in March 2023. This nasal spray is the first and only approved zavegepant (CGRP receptor antagonist) for acute migraine treatment. It functions by targeting the calcitonin gene-related peptide (CGRP), and is specifically engineered for acute migraine relief. The authorization of Zavzpret presents a fresh treatment alternative for those suffering from migraines, including those who experience nausea and vomiting during migraine episodes and those unable to use triptans due to cardiovascular risks.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/migraine-drugs-global-market-report
What Are the Top Revenue-Generating Geographies in the Migraine Drugs Market?
North America was the largest region in the migraine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the migraine drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Migraine Drugs Market?
2. What is the CAGR expected in the Migraine Drugs Market?
3. What Are the Key Innovations Transforming the Migraine Drugs Industry?
4. Which Region Is Leading the Migraine Drugs Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Migraine Drugs Market Size Projected To Reach $7.22 Billion By 2034 With A Cagr Of 5.8% here
News-ID: 4027367 • Views: …
More Releases from The Business Research Company
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025?
Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual…
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Rheology Modifiers Industry?
There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound…
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025?
In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth…
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Pharmaceutical Intermediates Industry?
There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound…
More Releases for Migraine
Leading Growth Driver in the Migraine Market Share in 2025: Rising Prevalence Of …
What Market Share dynamics are playing a key role in accelerating the growth of the migraine Market Share?
The migraine Market Share is projected to grow, driven by the rising occurrence of migraines. Migraines, a kind of headache that typically affects one side of the brain and causes intense, throbbing pain or a pulsing sensation, can be managed and relief can be provided via proper treatment. This treatment paves the way…
Emerging Acute Migraine Treatment Market Trend 2025-2034: Innovative CGRP Recept …
How Is the Acute Migraine Treatment Market Projected to Grow, and What Is Its Market Size?
The market size for acute migraine treatment has witnessed substantial growth in the past few years. Forecasts expect it to expand from $2.6 billion in 2024 to $2.91 billion in 2025, boasting a compound annual growth rate (CAGR) of 11.6%. Factors contributing to this growth in the historical period include the rising incidence of migraines,…
Key Influencer in the Migraine Market 2025: Rising Prevalence Of Migraine Drives …
"What Is the Forecasted Market Size and Growth Rate for the Migraine Market?
The migraine market is projected to grow steadily from $1.93 billion in 2024 to $1.97 billion in 2025, at a CAGR of 2.2%. This growth is attributed to the rising prevalence of migraines, growing awareness of treatment options, government initiatives, increased alcohol consumption, and lifestyle changes.
Migraine Market: Expected to grow to $2.25 billion by 2029 at a CAGR…
How Big is Migraine Drugs Market?
In 2022, the Global Migraine Drugs Market soared to USD 10,972.1 million, marking a significant milestone. Projections indicate a promising trajectory, with expectations set for substantial growth, potentially reaching USD 26,618.96 million by 2031. Forecasts for the period between 2024 and 2031 suggest a robust Compound Annual Growth Rate (CAGR) of 12.1% for the migraine drugs market.
The objectives outlined in the report are multifaceted and aimed at offering a comprehensive…
Migraine Therapeutics Market - Relieve the Burden: Empowering Lives through Migr …
Newark, New Castle, USA - new report, titled Migraine Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Migraine Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Migraine Therapeutics market. The report offers an overview of the market, which…
Rise in Prevalence of Migraine Drives the Migraine Drugs Market | Outlook 2025
Migraine is characterized by a recurrent throbbing headache, which affects only one side of the head. It is accompanied by vomiting, nausea and even altered vision in some cases.
The increase in the prevalence of migraine, the rapid increase in the female population and the increased awareness among patients for the treatment and prevention of migraine are driving the growth of the global market for anti-migraine drugs.
Get Access to TOC /…
